![Moderna Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/mrna.png?tr=w-200)
Moderna Inc
NASDAQ:MRNA
![Moderna Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/mrna.png)
Intrinsic Value
The intrinsic value of one
MRNA
stock under the Base Case scenario is
41.45
USD.
Compared to the current market price of 32.99 USD,
Moderna Inc
is
Undervalued by 20%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/mrna.png?tr=w-200)
Valuation History
Moderna Inc
Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
![](https://ik.imagekit.io/kkbzr2uz4cp/landing/historical-valuation/example-2.png)
Fundamental Analysis
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/mrna.png?tr=w-128)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/mrna.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/other/ai-assistant.png)
Revenue & Expenses Breakdown
Moderna Inc
Balance Sheet Decomposition
Moderna Inc
Current Assets | 9.7B |
Cash & Short-Term Investments | 6.9B |
Receivables | 1.8B |
Other Current Assets | 963m |
Non-Current Assets | 6.1B |
Long-Term Investments | 2.4B |
PP&E | 3.2B |
Intangibles | 93m |
Other Non-Current Assets | 521m |
Free Cash Flow Analysis
Moderna Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Moderna Inc
Revenue
|
5.1B
USD
|
Cost of Revenue
|
-1.1B
USD
|
Gross Profit
|
4B
USD
|
Operating Expenses
|
-6.1B
USD
|
Operating Income
|
-2.1B
USD
|
Other Expenses
|
-89m
USD
|
Net Income
|
-2.2B
USD
|
MRNA Profitability Score
Profitability Due Diligence
Moderna Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/mrna.png)
Score
Moderna Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
MRNA Solvency Score
Solvency Due Diligence
Moderna Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/mrna.png)
Score
Moderna Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MRNA Price Targets Summary
Moderna Inc
According to Wall Street analysts, the average 1-year price target for
MRNA
is 70.73 USD
with a low forecast of 27.27 USD and a high forecast of 222.6 USD.
Dividends
Current shareholder yield for MRNA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MRNA
stock under the Base Case scenario is
41.45
USD.
Compared to the current market price of 32.99 USD,
Moderna Inc
is
Undervalued by 20%.